logo

Last Update

This profile was last updated on 7/20/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Matthew Pollman?

Matthew Pollman

Director of Cardiovascular Biology and Molecular Medicine

Millennium Pharmaceuticals , Inc.

HQ Phone:  (617) 679-7000

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Millennium Pharmaceuticals , Inc.

40 Landsdowne Street

Cambridge, Massachusetts,02139

United States

Company Description

Millennium: The Takeda Oncology Company , a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor in the US, and has a robust clinical development pipeline of global product candidates. Millennium Pharmaceut...more

Background Information

Affiliations

Juventas Therapeutics Inc

Board Member


Global Cardiovascular Innovation Center

Member of the Commercialization Advisory Board


Cardionomic Inc

Board Member


Merlot OrthopediX Inc

Board Member


Morehouse School of Medicine

Full-Time Faculty Member


Harvard Companies, Inc.

Full-Time Faculty Member


Education

B.S. degree

Southwestern Adventist University


M.D


M.D. degrees

Loma Linda University


M.S.


Web References(24 Total References)


Commercialization Advisory Board | GCIC | Global Cardiovascular Innovation Center in Cleveland, Ohio GCIC | Global Cardiovascular Innovation Center in Cleveland, Ohio

gcic.org [cached]

Matt Pollman, MD
Consultant, Cardiovascular Therapeutic and Diagnostics Matthew Pollman, consultant, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics. He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhI/PhII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.


www.ncai-cc.ccf.org

Matthew Pollman, MD, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics.
He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhaseI/PhaseII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.


Commercialization Advisory Board | GCIC | Global Cardiovascular Innovation Center in Cleveland, Ohio GCIC | Global Cardiovascular Innovation Center in Cleveland, Ohio

gcic.org [cached]

Matt Pollman, MD
Consultant, Cardiovascular Therapeutic and Diagnostics Matthew Pollman, consultant, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics. He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhI/PhII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.


Attraction Program Advisory Board | GCIC | Global Cardiovascular Innovation Center in Cleveland, Ohio

gcic.org [cached]

Matt Pollman, MD
Matt Pollman, MD Consultant, Cardiovascular Therapeutic and Diagnostics Matthew Pollman, consultant, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics. He has most recently served as Medical Director, R&D, for Abbott Vascular. In this role, Dr. Pollman was the principal medical and scientific advisor for the R&D and Business Development organizations. Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhI/PhII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies. Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals. Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles. He has served on the faculties of Harvard Medical School and Morehouse School of Medicine.


Biomedical Startup Guided Interventions Establishes Roots in Lorain County - GLIDE, Entrepreneur Resources

www.glideit.org [cached]

Guided Interventions CEO, Dr. Matthew Pollman, a cardiologist and cardiovascular molecular biologist, plans to use the staff of the Desich SMART Center, a MEMS packaging, assembly, and test development foundry, to help integrate and test the sensor.
"I was incredibly impressed by the level of competency among the individuals at the Desich SMART Center," said Dr. Pollman.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory